Market Overview

Top 4 Large-Cap Stocks In The Biotechnology Industry With The Lowest PEG Ratio

Related GILD
Jim Cramer Shares His Thoughts On Gilead Sciences, Inc. And Citigroup Inc
Fast Money Traders Share Their Biotech Picks
–… Biotech and Specialty Pharma Bargains: Do You Have the Guts to Speculate? (GuruFocus)
Related CELG
Celgene To See Major Upside In 2017, Says Canaccord
Celgene's Phase 3 Study Of REMARC Likely To Be Successful, Says Jefferies
Celgene Unlocking Value Through Industry Dominance (Seeking Alpha)

Below are the top large-cap biotechnology stocks on the NYSE and the NASDAQ in terms of PEG ratio.

Gilead Sciences (NASDAQ: GILD) has a PEG ratio of 0.62. Gilead Sciences' trailing-twelve-month revenue is $11.20 billion.

Celgene (NASDAQ: CELG) has a PEG ratio of 0.93. Celgene's trailing-twelve-month operating margin is 30.49%.

Alexion Pharmaceuticals (NASDAQ: ALXN) has a PEG ratio of 1.63. Alexion Pharma's trailing-twelve-month EPS is $1.27.

Biogen Idec (NASDAQ: BIIB) has a PEG ratio 1.67. Biogen Idec's trailing-twelve-month ROE is 23.90%.

Posted-In: Biotechnology Industry Large-Cap PEG ratioTrading Ideas


Related Articles (ALXN + BIIB)

View Comments and Join the Discussion!